Charles S Fuchs Selected Research

Microsatellite Instability

6/2021	Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
8/2020	Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction.
1/2020	Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
6/2019	Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.
1/2019	Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
1/2019	Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).
1/2019	Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells.
12/2018	The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.
11/2018	Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
10/2018	Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles S Fuchs Research Topics

Disease

241	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 03/2002
231	Neoplasms (Cancer) 11/2022 - 01/2002
86	Colonic Neoplasms (Colon Cancer) 01/2022 - 03/2002
67	Microsatellite Instability 06/2021 - 01/2006
55	Carcinogenesis 10/2021 - 09/2002
50	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2002
37	Adenocarcinoma 01/2022 - 12/2005
32	Adenoma (Adenomas) 01/2021 - 03/2002
19	Carcinoma (Carcinomatosis) 01/2019 - 08/2003
19	Rectal Neoplasms (Rectal Cancer) 11/2018 - 04/2003
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2002
14	Inflammation (Inflammations) 12/2020 - 03/2010
13	Obesity 01/2020 - 08/2003
12	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 06/2002
11	Disease Progression 01/2022 - 12/2008
11	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 09/2004
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2004
10	Hypertension (High Blood Pressure) 01/2021 - 11/2005
8	Crohn Disease (Crohn's Disease) 01/2022 - 03/2012
8	Leukemia 01/2022 - 09/2008
8	Polyps 01/2021 - 07/2004
8	Insulin Resistance 02/2020 - 11/2005
8	Neutropenia 01/2019 - 01/2004
7	Hyperinsulinism (Hyperinsulinemia) 08/2020 - 04/2005
7	Overweight 06/2015 - 09/2002
7	Ulcerative Colitis 06/2015 - 03/2012
7	Carcinoid Tumor (Carcinoid) 08/2012 - 01/2004
6	Neoplasm Metastasis (Metastasis) 12/2017 - 08/2006
6	Diarrhea 02/2007 - 01/2003
5	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2005

Drug/Important Bio-Agent (IBA)

51	Biomarkers (Surrogate Marker)IBA 06/2021 - 06/2005
40	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 01/2006
38	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 08/2002
29	Fluorouracil (Carac)FDA LinkGeneric 08/2021 - 04/2002
28	Vitamin D FDA LinkGeneric 01/2021 - 09/2004
27	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 03/2003
25	NucleotidesIBA 08/2020 - 07/2007
25	Folic Acid (Vitamin M)FDA LinkGeneric 12/2015 - 03/2002
23	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 05/2005
21	25-hydroxyvitamin DIBA 01/2021 - 09/2004
20	Insulin (Novolin)FDA Link 01/2021 - 01/2005
20	hydroxide ionIBA 11/2020 - 09/2004
17	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2003
17	C-PeptideIBA 08/2020 - 01/2005
17	beta CateninIBA 10/2018 - 07/2007
16	Biological ProductsIBA 11/2022 - 04/2002
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021 - 01/2003
15	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2012 - 01/2006
14	pembrolizumabIBA 01/2022 - 01/2018
13	Pharmaceutical PreparationsIBA 08/2021 - 08/2003
13	ErbB Receptors (EGF Receptor)IBA 08/2021 - 12/2004
13	Proteins (Proteins, Gene)FDA Link 03/2018 - 06/2005
13	CarbonIBA 11/2015 - 12/2004
12	TabletsIBA 01/2022 - 08/2002
12	Cisplatin (Platino)FDA LinkGeneric 08/2021 - 04/2002
12	CalciumIBA 01/2020 - 03/2002
12	Gemcitabine FDA Link 01/2019 - 01/2002
12	Insulin-Like PeptidesIBA 03/2016 - 04/2005
11	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2005
11	ParaffinIBA 01/2020 - 08/2005
11	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 08/2002
11	Hormones (Hormone)IBA 01/2016 - 08/2002
10	RamucirumabIBA 10/2020 - 01/2014
10	CateninsIBA 01/2018 - 03/2011
10	EnzymesIBA 01/2016 - 08/2004
9	Coffee FDA Link 01/2022 - 02/2005
9	Cetuximab (Erbitux)FDA Link 01/2022 - 05/2006
9	AdiponectinIBA 01/2021 - 11/2005
9	Cyclin D1IBA 03/2011 - 01/2009
8	PlatinumIBA 08/2021 - 08/2003
8	Monoclonal AntibodiesIBA 01/2019 - 12/2005
7	Capecitabine (Xeloda)FDA Link 08/2021 - 01/2003
7	LigandsIBA 08/2021 - 12/2005
7	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2020 - 11/2014
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2005
7	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018 - 03/2010
7	Tumor Biomarkers (Tumor Markers)IBA 12/2017 - 06/2012
7	Tyrosine Kinase InhibitorsIBA 03/2013 - 09/2005
6	SugarsIBA 01/2021 - 06/2004
6	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018 - 07/2009
6	Vitamin B 6IBA 04/2013 - 05/2005
6	Methionine (L-Methionine)FDA Link 01/2011 - 03/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2017
5	IronIBA 10/2021 - 06/2005
5	ORALIT (ORS)IBA 01/2021 - 02/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2013
5	Cholecalciferol (Vitamin D3)FDA Link 01/2021 - 02/2014
5	Dinoprostone (PGE2)FDA Link 01/2019 - 03/2010
5	Indicators and Reagents (Reagents)IBA 12/2018 - 04/2006
5	Dietary Fiber FDA Link 01/2018 - 12/2005
5	Oral ContraceptivesIBA 01/2016 - 08/2002
5	ElementsIBA 11/2015 - 04/2011

Therapy/Procedure

72	Therapeutics 01/2022 - 04/2002
61	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
28	Adjuvant Chemotherapy 01/2022 - 08/2002
9	Radiotherapy 11/2017 - 04/2003
7	Immunotherapy 06/2021 - 01/2016
6	Precision Medicine 01/2020 - 08/2011
6	Chemoprevention 11/2015 - 03/2005
6	Combination Drug Therapy (Combination Chemotherapy) 05/2007 - 01/2004